Skip to main content

Published locations for Alemtuzumab provides greater reductions in serum NfL than interferon beta-1a

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Alemtuzumab provides greater reductions in serum NfL than interferon beta-1a

User login

  • Reset your password
  • /content/alemtuzumab-provides-greater-reductions-serum-nfl-interferon-beta-1a
  • /neurologyreviews/article/201634/multiple-sclerosis/alemtuzumab-provides-greater-reductions-serum-nfl
  • /multiplesclerosishub/article/201634/multiple-sclerosis/alemtuzumab-provides-greater-reductions-serum
  • /neurology/article/201634/multiple-sclerosis/alemtuzumab-provides-greater-reductions-serum-nfl
  • /neurology/msresourcecenter/article/201634/multiple-sclerosis/alemtuzumab-provides-greater-reductions
  • /clinicalneurologynews/article/201634/multiple-sclerosis/alemtuzumab-provides-greater-reductions